China Smart Insulin Pens Market to Reach USD392 Million by 2030 Due to Widespread Incidence of Diabetes

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The China Smart Insulin Pens Market size was valued at around USD129 million in 2024 and is projected to reach USD392 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 20.35% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. Major contributing growth factors comprise the rapidly rising number of diabetic patients, the older population, and the adoption of digital and non-invasive medical devices in the country.

Additionally, the government is investing in and encouraging the adoption of smart and digital medical devices in the healthcare sector by implementing various policies such as the Medical Device Administration Law, Multi-Level Protection Scheme, Medical Device Standards, etc., therefore, contributing to the potential market growth. Also, the integration of other systems such as continuous glucose monitoring systems (CGMs) and Electronic Health Records (EHR) with smart insulin pens is a more convenient and modernized version of smart medical devices, including smart insulin pens, therefore, increasing the market demand.

The elderly population is more prone to chronic disorders, including diabetes. China has the largest older population globally, which is creating a demand for safe, remote, and advanced medication for diabetes including insulin hormones. It is leading to the rapid growth of the smart insulin pens market in China. Furthermore, the development of healthcare infrastructure in China increases hospital visits of patients even in remote and rural areas of the country. Thus, increasing the number of hospital pharmacies which are the primary distribution channel for diabetic patients to purchase insulin delivery systems such as smart insulin pens.

The cyber threat is one of the major challenges for the smart insulin pens market in China. These can be connected to mobile applications which can lead to cyber corruption and less data security as the personal information of the individual is collected by the applications and results in data breach. Thus, hindering the market’s growth, further states the research report, “China Smart Insulin Pens Market Analysis, 2025.”

Segmentation Analysis

Second-Generation Pens Attract a Large Group of End-Users

Based on the product type, the market is further bifurcated into first-generation pens and second-generation pens. Between the two, second-generation pens are leading the market with a significant market share of more than 55%. Second-generation smart insulin pens are more advanced as compared to the 1^st generation pens due to technological advancements. These pens allow the customers to choose a more convenient option for insulin delivery systems. The integration of 2^nd generation smart insulin pens with mobile apps via Bluetooth and internet connections is transforming the market as it provides smooth, precise, and accurate insulin delivery to patients when needed.

Therefore, many manufacturers are getting approval from the regulatory agencies of China, such as the National Medical Products Administration (NMPA) for the advanced 2^nd generation pens, thus contributing to the market’s growth through their high adoption rate in China.

Hospital Pharmacies are the Most Preferred Distribution Channel

Hospital Pharmacies maintain a significant position in the China Smart Insulin Pens Industry with a market share of more than 40%. The growth of this segment is pushed through the growing improvement of the healthcare infrastructure in China, which is similarly fueled through the fast adoption of advanced medical devices and gadgets in pharmacies. Additionally, the hospitals control a massive number of patients at a time, consequently, there is a huge demand for greater dispensaries and pharmacies in the health center premises. It creates flexibility and accessibility to the customers, and they prefer to purchase such devices, including smart insulin pens, from the very first distribution channel near them after getting the prescription.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Jiangsu Delfu Medical Device Co., Ltd., Novo Nordisk A/S, Sinocare Inc., Medtronic plc, Ypsomed AG, Eli Lilly and Company, Sanofi S.A., Emperra GmbH E-Health Technologies, Bigfoot Biomedical Inc., Digital Medics Pty Ltd., and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the country?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across the country?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?